(Q24299664)

10

object named as

Tesshi Yamada

0 references

Kazufumi Honda

4

object named as

Kazufumi Honda

0 references

author name string

Lin Huang

1

0 references

Miki Shitashige

2

0 references

Reiko Satow

3

0 references

Masaya Ono

5

0 references

Jisoo Yun

6

0 references

Akihiro Tomida

7

0 references

Takashi Tsuruo

Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics

8

0 references

language of work or name

English

0 references

publication date

November 2007

0 references

published in

Gastroenterology

0 references

volume

133

0 references

issue

5

0 references

page(s)

1569-78

0 references

cites work

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Etoposide: A Semisynthetic Epipodophyllotoxin Chemistry, Pharmacology, Pharmacokinetics, Adverse Effects and Use as an Antineoplastic Agent

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Inhibition of protein-protein interactions: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Bipartite nuclear localization signals in the C terminus of human topoisomerase II alpha.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Cancer genetics: colorectal cancer as a model.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Inactivation of the E-cadherin-mediated cell adhesion system in human cancers

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Lessons from hereditary colorectal cancer

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Small-molecule antagonists of the oncogenic Tcf/beta-catenin protein complex

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Epigenetic changes in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Drosophila Tcf and Groucho interact to repress Wingless signalling activity.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Chibby, a nuclear beta-catenin-associated antagonist of the Wnt/Wingless pathway

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Cellular roles of dna topoisomerases: a molecular perspective

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Poly(ADP-ribose) polymerase-1 is a component of the oncogenic T-cell factor-4/beta-catenin complex.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Involvement of splicing factor-1 in beta-catenin/T-cell factor-4-mediated gene transactivation and pre-mRNA splicing.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Dose-dense chemotherapy in breast cancer and lymphoma

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Casein kinase I phosphorylates and destabilizes the beta-catenin degradation complex

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected]

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Regulation of beta -catenin transformation by the p300 transcriptional coactivator.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

beta-catenin is a target for the ubiquitin-proteasome pathway

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

The current status of camptothecin analogues as antitumor agents

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Tumor formation by genetic mutations in the components of the Wnt signaling pathway

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

A topoisomerase IIbeta-mediated dsDNA break required for regulated transcription.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Identification of c-MYC as a target of the APC pathway

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Phase II study of irinotecan and etoposide in patients with metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Leucine zipper in human DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Etoposide: discovery and medicinal chemistry

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021

Lineage commitment and maturation of epithelial cells in the gut.

1 reference

https://api.crossref.org/works/10.1053%2FJ.GASTRO.2007.08.011

7 January 2021